A novel mutation in the AVPR2 gene (222delA) associated with X-linked nephrogenic diabetes insipidus in a boy with growth failure.

Détails

ID Serval
serval:BIB_284D847FF7D6
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
A novel mutation in the AVPR2 gene (222delA) associated with X-linked nephrogenic diabetes insipidus in a boy with growth failure.
Périodique
Endocrine practice
Auteur⸱e⸱s
Abaci A., Wood K., Demir K., Büyükgebiz A., Böber E., Kopp P.
ISSN
1934-2403 (Electronic)
ISSN-L
1530-891X
Statut éditorial
Publié
Date de publication
2010
Peer-reviewed
Oui
Volume
16
Numéro
2
Pages
231-236
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article
Publication Status: ppublish
Résumé
To study the case of a 2 10/12-year-old boy who had growth failure and delayed bone maturation.
We reviewed the history, which revealed that he had had polyuria, polydipsia, lack of weight gain, and frequent vomiting since the age of 5 months. On physical examination, his height was 86 cm (-1.93 standard deviation [SD]), his weight 10.5 kg (-2.67 SD), and he had motor and mental retardation. His maternal great-grandfather also had polyuria and polydipsia (but not diabetes mellitus), suggesting X-linked nephrogenic diabetes insipidus as the underlying cause. The patient underwent a water deprivation-desmopressin test. The coding region of the AVPR2 gene was amplified by polymerase chain reaction and submitted to direct sequence analysis.
The water deprivation test confirmed the diagnosis of diabetes insipidus, and administration of desmopressin did not diminish his water secretion. Direct sequencing of the AVPR2 gene revealed a novel deletion of adenine at position 222 (222delA) in exon 2. This mutation is predicted to lead to a frameshift beginning at amino acid 75 and a premature stop codon at position 115 (FS75>115X). His height and weight, as well as his motor skills, improved after initiation of therapy with hydrochlorothiazide and amiloride.
Growth delay can be associated with diabetes insipidus. The X-linked nephrogenic diabetes insipidus in this boy is caused by a novel mutation in the AVPR2 gene that is predicted to truncate the receptor protein.
Mots-clé
Amiloride/therapeutic use, Child, Preschool, Diabetes Insipidus, Nephrogenic/drug therapy, Diabetes Insipidus, Nephrogenic/genetics, Genetic Diseases, X-Linked/drug therapy, Genetic Diseases, X-Linked/genetics, Humans, Hydrochlorothiazide/therapeutic use, Male, Mutation, Receptors, Vasopressin/genetics, Sodium Channel Blockers/therapeutic use
Pubmed
Web of science
Création de la notice
30/12/2020 14:46
Dernière modification de la notice
31/12/2020 7:26
Données d'usage